Status:
UNKNOWN
Low Energy HoLEP on IPSS
Lead Sponsor:
Seoul National University Hospital
Conditions:
Prostate Hyperplasia
Prostatic Hypertrophy
Eligibility:
MALE
50-90 years
Phase:
NA
Brief Summary
The purpose of this study is to prove that low-energy (30W) Holmium laser prostatectomy (Holeb) is not inferior to high-energy (100W) Holmium laser prostatectomy (safety and effectiveness)
Detailed Description
1. Overview of the study Research design: prospective, single-arm blind randomized control study, non-inferiority study Study Period: 12 months since IRB approval date Subject: Patients with benign pr...
Eligibility Criteria
Inclusion
- Selection criteria Men over 50 Patients receiving HoLEP due to an enlarged prostate Patients who fully understood and agreed to the study
- Exclusion criteria Patients with neuropathy that may adversely affect the urination function (Parkinson's disease, dementia, etc.) Patients with acute urinary lung disease within the last month Patients with symptomatic urinary tract infection In case there are other factors that can significantly affect treatment results at the discretion of the researcher
Exclusion
Key Trial Info
Start Date :
August 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04514718
Start Date
August 24 2020
End Date
December 31 2020
Last Update
August 17 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.